{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:37:02Z","timestamp":1791265022289,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035416","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T20:58:01Z","timestamp":1336597081000},"page":"e35416","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Single DermaVir Immunization: Dose-Dependent Expansion of Precursor\/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct00712530","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Julianna","family":"Lisziewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyasha","family":"Bakare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Calarota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9nes","family":"B\u00e1nhegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Szl\u00e1vik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"\u00dajhelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u0151 R.","family":"T\u0151ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Lisziewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Autran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Lori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/644772","article-title":"Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late nitiation, and early discontinuation of antiretroviral therapy.","volume":"49","author":"E Losina","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri1706","article-title":"Perils at mucosal front lines for HIV and SIV and their hosts.","volume":"5","author":"AT Haase","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaci.2008.05.033","article-title":"Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.","volume":"122","author":"L Shen","year":"2008","journal-title":"J Allergy Clin Immun"},{"issue":"7","key":"ref4","first-page":"894","article-title":"A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis.","volume":"203","author":"H Hatano","year":"2011"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":"Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.","volume":"106","author":"JB Dinosoa","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","first-page":"1","article-title":"The effect of Raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.","volume":"7","author":"RT Gandhi","year":"2011","journal-title":"PLoS Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/650749","article-title":"Short-course Raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.","volume":"50","author":"D McMahon","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2010-11-320226","article-title":"HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.","volume":"117","author":"AG Chapuis","year":"2011","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.vaccine.2010.11.019","article-title":"A plasmid DNA immunogen expressing fifteen protein antigens and complex virus-like particles (VLP+) mimicking naturally occurring HIV.","volume":"29","author":"E Somogyi","year":"2011","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2010.03.048","article-title":"Rational development of a stable liquid formulation for nanomedicine products.","volume":"392","author":"ER Toke","year":"2010","journal-title":"Int J Pharm"},{"key":"ref11","article-title":"Structure and biological activity of pathogen-like synthetic nanomedicines.","author":"O Lorincz","year":"2011"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1128\/JVI.75.16.7621-7628.2001","article-title":"Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells.","volume":"75","author":"J Lisziewicz","year":"2001","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0022-202X.2004.23535.x","article-title":"DermaVir: a novel topical vaccine for HIV\/AIDS.","volume":"124","author":"J Lisziewicz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2007.04.012","article-title":"HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.","volume":"366","author":"AD Cristillo","year":"2007","journal-title":"Virology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-200501030-00004","article-title":"Control of viral rebound through therapeutic immunization with DermaVir.","volume":"19","author":"J Lisziewicz","year":"2005","journal-title":"AIDS"},{"key":"ref16","article-title":"Central memory and effector memory T cell subsets: function, generation and maintenance.","volume":"45\u2013763","author":"F Sallusto","year":"2004","journal-title":"Annu Rev Immunol 22:7"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+T cells.","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2005-07-2907","article-title":"Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study.","volume":"107","author":"CA Jansen","year":"2006","journal-title":"Blood"},{"key":"ref19","first-page":"1","article-title":"Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.","volume":"3","author":"IMM Schellens","year":"2008","journal-title":"PLoSOne"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.4049\/jimmunol.175.9.5675","article-title":"Durable human memory T cells quantifiable by Cultured Enzyme-Linked Immunospot Assays are induced by heterologous prime boost immunization and correlate with protection against malaria.","volume":"175","author":"SM Keating","year":"2005","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.4049\/jimmunol.180.9.5907","article-title":"HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals.","volume":"180","author":"SA Calarota","year":"2008","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.4049\/jimmunol.167.8.4729","article-title":"Unique T cell effector functions elicited by plasmodium falciparum epitopes in malaria-exposed africans tested by three T cell assays.","volume":"167","author":"KL Flanagan","year":"2001","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.4049\/jimmunol.169.4.2210","article-title":"Evolution of epitope-specific memory CD4 T cells after clearance of Hepatitis C virus.","volume":"169","author":"AJ Godkin","year":"2002","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self.","volume":"296","author":"P Matzinger","year":"2002","journal-title":"Science"},{"key":"ref25","article-title":"A Model System Using Tape Stripping for Characterization of Langerhans Cell-Precursors In Vivo.","volume":"\u20131174","author":"S Holzmann","year":"2004","journal-title":"J Invest Dermatol 122: 1165"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/eji.200636508","article-title":"Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.","volume":"36","author":"BO Ondondo","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/088922200750006038","article-title":"Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.","volume":"16","author":"DW Notermans","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1128\/JVI.75.14.6508-6516.2001","article-title":"Decay kinetics of Human Immunodeficiency Virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.","volume":"75","author":"JP Casazza","year":"2001","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"RA Koup","year":"1994","journal-title":"J Virol"},{"key":"ref30","first-page":"127","article-title":"Rational design of formulated DNA vaccine: The DermaVir approach.","author":"E Natz","year":"2011"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival.","volume":"360","author":"MM Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral Treatment of Adult HIV Infection: 2010 Recommendations of the International AIDS Society\u2013USA Panel.","volume":"304","author":"MA Thompson","year":"2010","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.4049\/jimmunol.180.12.7907","article-title":"Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression.","volume":"180","author":"K Ladell","year":"2008","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T10:47:52Z","timestamp":1594118872000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035416"}},"subtitle":[],"editor":[{"given":"Mark","family":"Wainberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,9]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035416","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,9]]}}}